Birnbach Communications’ Top Predictions for 2011, The Top 12 Business & Technology Stories, Part IV
FirstWord Pharma: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
Le Lezard: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
CommPro.Biz: “We Hate the Phrase “New Normal” But Here are 7 Marketing Tips for Navigating the You-Know-What” (Dec. 5, 2022)
Hebrew SeniorLife: “Hebrew SeniorLife’s Dr. Alvaro Pascual-Leone Named Top 10 Neuroscientist by Research.com”
Pharmaceutical Technology: “Coronavirus company news summary- France drops Merck’s anti-Covid-19 pill order- BiondVax signs deal for nanosized Covid-19 therapy”
Opera News: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
Hebrew SeniorLife: “Hebrew SeniorLife Appoints New Medical Director for Hebrew Rehabilitation Center: Dr. Matthew Shuster brings years of experience in compassionate and coordinated care”
WSJ Offers Examples of Overly Complicated Corporate Descriptions
Market Screener: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale: New data shows protein-based AKS-452 vaccine is shelf-stable for six months at 25° C (77° F)”
How to Combat Fake News
Worcester Business Journal: “French pharmaceutical company to open 15K-sq.-ft. Devens research center” (Jan. 11, 2023)